ArticleAmerican journal of translational research2021

Efficacy and safety of bevacizumab combined with temozolomide in the treatment of recurrent malignant gliomas and its influence on serum tumor markers.

Jun Lei et al.PubMed ↗Full text ↗

No numbers read from the abstract.